{"id":13379,"date":"2018-10-31T09:00:27","date_gmt":"2018-10-31T08:00:27","guid":{"rendered":"https:\/\/mileon.wordpress.com\/?p=13379"},"modified":"2018-10-31T09:00:27","modified_gmt":"2018-10-31T08:00:27","slug":"consenso-ada-easd-tratamiento-diabetes-tipo-2-resultados-del-estudio-tandem-y-mas","status":"publish","type":"post","link":"https:\/\/www.icscyl.com\/mileon\/otras-presentaciones\/2018-10-31\/consenso-ada-easd-tratamiento-diabetes-tipo-2-resultados-del-estudio-tandem-y-mas\/","title":{"rendered":"Consenso ADA-EASD tratamiento diabetes tipo 2, resultados del estudio TANDEM, y m\u00e1s&#8230;"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-thumbnail wp-image-13384\" src=\"https:\/\/mileon.files.wordpress.com\/2018\/10\/47c7908f410a4c7b8f3a344eff4058f1_m.jpg?w=150\" alt=\"47c7908f410a4c7b8f3a344eff4058f1_M\" width=\"150\" height=\"100\" \/>La sesi\u00f3n bibliogr\u00e1fica presentada el pasado viernes 19 de Octubre, por la Dra. Fern\u00e1ndez repas\u00f3 diferentes trabajos publicados en la revista Diabetolog\u00eda y Diabetes Care:<\/p>\n<ul>\n<li>Managemet of hyperglycaemia en type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD): un documento de consenso muy interesante en el que destaca el posicionamiento de los inhibidores SLGT-2 y agonistas GLP1 que se situan en el siguiente escal\u00f3n tras la metformina, optando por uno u otro en funci\u00f3n de las comorbilidades del paciente&#8230; el resto quedan posicionados en un tercer escal\u00f3n.<\/li>\n<li>HbA1C and hypoglycemia reductions at 24 and 52 weeks with sotaglifozin in combination with insulin in adults with type 1 diabetes: se comentaron los resultados del estudio TANDEM 1 y 2 realizados en Europa y EEUU que mostraban eficacia del f\u00e1rmaco en pacientes diab\u00e9ticos tipo 1 con menor incidencia de hipoglucemia grave.<\/li>\n<li>Trends in hospital admission for diabetic ketoacidosis in adults with type 1 and type 2 diabetes in England, 1998-2013: a retrospective cohort study. Las hospitalizaciones por cetoacidosis en Inglaterra van en aumento, solamente se ha conseguido reducir la estancia hospitalaria media.<\/li>\n<\/ul>\n<p>Su presentaci\u00f3n se encuentra disponible en este\u00a0<a href=\"https:\/\/drive.google.com\/open?id=1TOiW9mM8bkmte3XS9BzNla6IoqQRzqm6\">enlace.<\/a>\u00a0Aprovechamos la entrada tambi\u00e9n para adjuntar un cuadro-resumen del Dr. Borrego sobre la hiponatremia, en el que resume su etiolog\u00eda y manejo; su archivo se encuentra disponible\u00a0<a href=\"https:\/\/drive.google.com\/open?id=1Z3H2G7IeWIul8qHMM0QjQMtOonNN32nR\">aqu\u00ed.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La sesi\u00f3n bibliogr\u00e1fica presentada el pasado viernes 19 de Octubre, por la Dra. Fern\u00e1ndez repas\u00f3 diferentes trabajos publicados en la revista Diabetolog\u00eda y Diabetes Care: Managemet of hyperglycaemia en type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD): un documento de [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[719,722],"tags":[782,840],"class_list":["post-13379","post","type-post","status-publish","format-standard","hentry","category-otras-presentaciones","category-sesiones-bibliograficas","tag-borrego","tag-esther-fernandez"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/13379","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/comments?post=13379"}],"version-history":[{"count":0,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/13379\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/media?parent=13379"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/categories?post=13379"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/tags?post=13379"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}